|
gptkbp:instanceOf
|
gptkb:biotechnology
gptkb:public_company
|
|
gptkbp:acquiredBy
|
gptkb:Horizon_Therapeutics
gptkb:Immunex
gptkb:Onyx_Pharmaceuticals
gptkb:deCODE_genetics
|
|
gptkbp:CEO
|
gptkb:Robert_A._Bradway
|
|
gptkbp:focus
|
biopharmaceuticals
human therapeutics
|
|
gptkbp:foundedBy
|
gptkb:David_Baltimore
gptkb:Paul_Berg
gptkb:Arnold_O._Beckman
gptkb:Raymond_F._Baddour
gptkb:George_Rathmann
gptkb:Edward_Penhoet
gptkb:Francois_Michel
gptkb:Franklin_E._Johnson
gptkb:John_M._Baxter
gptkb:Leonard_Riggs
gptkb:Raymond_Baddour
gptkb:Robert_A._Swanson
gptkb:William_Bowes
gptkb:William_K._Bowes,_Jr.
gptkb:Winfried_Denk
|
|
gptkbp:foundedYear
|
1980
|
|
gptkbp:founder
|
gptkb:George_Rathmann
|
|
gptkbp:headquartersLocation
|
gptkb:Thousand_Oaks,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Amgen, Inc.
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:memberOf
|
gptkb:NASDAQ-100
gptkb:S&P_500
|
|
gptkbp:netIncome
|
$6.7 billion (2023)
|
|
gptkbp:notableInvention
|
gptkb:filgrastim
recombinant human growth hormone
|
|
gptkbp:notableProduct
|
gptkb:Aimovig
gptkb:Aranesp
gptkb:Enbrel
gptkb:Epogen
gptkb:Neulasta
gptkb:Prolia
gptkb:Repatha
gptkb:Xgeva
|
|
gptkbp:numberOfEmployees
|
2023
~25,200 (2023)
|
|
gptkbp:parentCompany
|
none
|
|
gptkbp:patent
|
over 1,000
|
|
gptkbp:revenue
|
$28.2 billion (2023)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
gptkb:AMGN
|
|
gptkbp:subsidiary
|
gptkb:Onyx_Pharmaceuticals
gptkb:deCODE_genetics
|
|
gptkbp:website
|
https://www.amgen.com/
|
|
gptkbp:bfsParent
|
gptkb:Donald_B._Rice
|
|
gptkbp:bfsLayer
|
6
|